激发试验
... 激动药||agonist 激发试验||rechallenge 激发态||excited state ...
再激发
当前新药成功研发为许多难治患者带来了新的曙光,但随之而来的药物不良反应,尤其是药物再激发(rechallenge)性肝损伤常导致治疗中断、甚至灾难性后果。
再攻击
... 隐性 recessive 再攻击 rechallenge 重组血小板因子4,肿瘤血管生长抑制剂 recombinant platelet factor ...
rechallenge:
re- + challenge
Challenge–dechallenge–rechallenge (CDR) is a medical testing protocol in which a medicine or drug is administered, withdrawn, then re-administered, while being monitored for adverse effects at each stage. The protocol is used when statistical testing is inappropriate due to an idiosyncratic reaction by a specific individual, or a lack of sufficient test subjects and unit of analysis is the individual. During the withdraw phase, the medication is allowed to wash out of the system in order to determine what effect the medication is having on an individual.